P311 binds to the latency associated protein and downregulates the expression of TGF-β1 and TGF-β2

Biochemical and Biophysical Research Communications

Volumn 315, Issue 4, 2004, Pages 1104-1109

  Paliwal, Seema ^a,b   Shi, Jinghua ^a   Dhru, Urmil ^a   Zhou, Yuanxiang ^a,c   Schuger, Lucia ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

LAP; P311; TGF 1; TGF 2; TGF 3

Indexed keywords

CELL PROTEIN; ISOPROTEIN; MESSENGER RNA; MUSCLE PROTEIN; PROTEIN P311; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; GENE DELETION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TWO HYBRID SYSTEM; YEAST;

EID: 1342281672     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.171     Document Type: Article

References (16)

1. Studler J.M., Glowinski J., Levi-Strauss M. An abundant mRNA of the embryonic brain persists at a high level in cerebellum, hippocampus and olfactory bulb during adulthood. Eur. J. Neurosci. 5:1993;614-623.
2. Varshavsky A. The ubiquitin system. Trends Biochem. Sci. 22:1997;383-387.
3. Noguchi M., Sarin A., Aman M.J., Nakajima H., Shores E.W., Henkart P.A., Leonard W.J. Functional cleavage of the common cytokine receptor gamma chain (gammac) by calpain. Proc. Natl. Acad. Sci. USA. 94:1997;11534-11539.
4. Shumway S.D., Maki M., Miyamoto S. The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain. J. Biol. Chem. 274:1999;30874-30881.
5. Ghose R., Shekhtman A., Goger M.J., Ji H., Cowburn D. A novel, specific interaction involving the Csk SH3 domain and its natural ligand. Nat. Struct. Biol. 8:2001;998-1004.
6. Fisher R.C., Olson M.C., Pongubala J.M., Perkel J.M., Atchison M.L., Scott E.W., Simon M.C. Normal myeloid development requires both the glutamine-rich transactivation domain and the PEST region of transcription factor PU.1 but not the potent acidic transactivation domain. Mol. Cell Biol. 18:1998;4347-4357.
7. Pan D., Zhe X., Jakkaraju S., Taylor G.A., Schuger L. P311 induces a TGF-beta1-independent, nonfibrogenic myofibroblast phenotype. J. Clin. Invest. 110:2002;1349-1358.
8. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 3:2002;349-363.
9. Martin P. Wound healing - aiming for perfect skin regeneration. Science. 276:1997;75-81.
10. Serini G., Gabbiani G. Mechanisms of myofibroblast activity and phenotypic modulation. Exp. Cell Res. 250:1999;273-283.
11. Annes J.P., Munger J.S., Rifkin D.B. Making sense of latent TGFbeta activation. J. Cell Sci. 116:2003;217-224.
12. Koli K., Saharinen J., Hyytiainen M., Penttinen C., Keski-Oja J. Latency, activation, and binding proteins of TGF-beta. Microsc. Res. Tech. 52:2001;354-362.
13. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 113:2003;685-700.
14. Piek E., Ju W.J., Heyer J., Escalante-Alcalde D., Stewart C.L., Weinstein M., Deng C., Kucherlapati R., Bottinger E.P., Roberts A.B. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J. Biol. Chem. 276:2001;19945-19953.
15. Taylor G.A., Hudson E., Resau J.H., Vande Woude G.F. Regulation of P311 expression by Met-hepatocyte growth factor/scatter factor and the ubiquitin/proteasome system. J. Biol. Chem. 275:2000;4215-4219.
16. Kuniyasu A., Kaneko K., Kawahara K., Nakayama H. Molecular assembly and subcellular distribution of ATP-sensitive potassium channel proteins in rat hearts. FEBS Lett. 552:2003;259-263.